7F9V

Toxoplasma gondii Prolyl-tRNA Synthetase (TgPRS) in Complex with inhibitor T35 and Halofuginone

CHAIN

A

X. oryzae mn riboswitch optimized construct - Xanthomonas oryzae

Explore Sequence Annotations in 3D

CHAIN A

EDS ATOMS

OCC WT AVG B

AVERAGE OCCUPANCY

ATOMIC CLASHES

RSRZ

RSR

RSCC

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MG

BINDING SITE MN

BINDING SITE MN

BINDING SITE SR

BINDING SITE SR

BINDING SITE SR

BINDING SITE SR

BINDING SITE SR

BINDING SITE SR

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MG

METAL COORDINATION MN

METAL COORDINATION SR

METAL COORDINATION SR

METAL COORDINATION SR

METAL COORDINATION SR

METAL COORDINATION SR

COVALENT BOND

MODIFIED MONOMER

LOADING 98%

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.